VirnetX Holding Corp
VHC Nasdaq Patent Owners & Lessors Financials FY2016βFY2025
What VirnetX Holding Corp does
No business description yet.
- Legal name
- VirnetX Holding Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 24, 2026
- Accession Β· CIK
- 0001140361-26-010895
0001082324
Revenue and margins
VirnetX Holding Corp had $0.2M of revenue in fiscal 2025, up 3,140.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$15.7M in fiscal 2025, β9,667.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
VirnetX Holding Corp returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably VirnetX Holding Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $169M | $152M | $53.5M | $38.1M | $21.5M |
| Current ratio | 166.0x | 208.3x | 42.9x | 5.3x | 10.7x |
| Quick ratio | 166.0x | 208.3x | 42.9x | 5.3x | 10.7x |
| Total assets | $187M | $153M | $60.4M | $49.6M | $31.1M |
| Total liabilities | $1.1M | $0.7M | $4.4M | $10.0M | $8.6M |
| Shareholders' equity | $185M | $152M | $56.0M | $39.6M | $22.5M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 7 | 3 / 7 | 2 / 7 | 6 / 7 | 2 / 7 | 4 / 7 | 2 / 7 | 3 / 7 | 4 / 7 |
| Accruals ratio | β35.2% | β17.9% | β32.8% | β42.6% | β0.8% | 4.2% | β11.4% | β2.9% | β5.2% | β6.4% |
| Altman Z'' | β32.06 | β95.04 | β59.41 | β105.62 | 33.14 | 185.76 | 222.35 | 5.52 | β7.95 | β20.70 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.6M | $1.5M | $0.1M | $0.1M | $303M | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M |
| Research and development | $4.2M | $4.2M | $4.8M | $3.8M | $8.8M | $5.6M | $6.4M | $9.7M | $6.0M | $5.7M |
| Operating income | β$28.5M | β$17.3M | β$25.5M | β$19.7M | $158M | β$49.2M | β$22.1M | β$31.4M | β$20.4M | β$19.4M |
| Pretax income | β$28.4M | β$17.3M | β$25.4M | β$19.6M | $307M | β$49.1M | β$20.2M | β$28.0M | β$18.2M | β$18.2M |
| Income tax | $0.1M | $0.0M | $0.0M | β$0.4M | $27.0M | β$6.2M | $16.0M | β$0.1M | $0.0M | β$0.0M |
| Net income | β$28.6M | β$17.3M | β$25.4M | β$19.2M | $280M | β$42.9M | β$36.3M | β$27.9M | β$18.2M | β$18.2M |
| Diluted EPS | β$0.51 | β$0.30 | β$0.40 | β$0.28 | $3.92 | β$0.60 | β$10.17 | β$7.79 | β$5.05 | β$5.00 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B | 0.07B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | β$21.9M | β$14.9M | β$22.3M | β$15.1M | $281M | β$51.7M | β$16.9M | β$24.8M | β$15.3M | β$15.6M |
| Capital expenditure | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M |
| Free cash flow | β$21.9M | β$14.9M | β$22.3M | β$15.1M | $281M | β$51.7M | β$16.9M | β$24.8M | β$15.3M | β$15.7M |
| Depreciation and amortization | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Stock-based compensation | $5.4M | $4.0M | $4.1M | $3.7M | $3.9M | $4.2M | $3.3M | $2.8M | $1.9M | $2.0M |
| Dividends paid | β | β | β | $0.0M | $70.8M | $0.0M | $0.0M | $71.4M | $0.0M | β |
| Dividends and buybacks | β | β | β | $0.0M | $70.8M | $0.0M | $0.0M | $71.4M | $0.0M | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $15.9M | $4.6M | $9.4M | $5.5M | $221M | $169M | $152M | $53.5M | $38.1M | $21.5M |
| Current assets | $16.5M | $5.2M | $10.1M | $5.8M | $224M | $169M | $152M | $53.8M | $38.2M | $21.7M |
| Current liabilities | $5.2M | $4.5M | $1.9M | $1.8M | $10.4M | $1.0M | $0.7M | $1.3M | $7.2M | $2.0M |
| Property and equipment, net | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | $0.1M | $0.1M |
| Total assets | $18.9M | $7.2M | $11.8M | $7.5M | $235M | $187M | $153M | $60.4M | $49.6M | $31.1M |
| Total liabilities | $7.7M | $5.6M | $1.9M | $1.9M | $10.4M | $1.1M | $0.7M | $4.4M | $10.0M | $8.6M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $11.1M | $1.6M | $9.9M | $5.6M | $224M | $185M | $152M | $56.0M | $39.6M | $22.5M |
| Margins | ||||||||||
| Operating margin | β1,839.0% | β1,119.7% | β40,407.9% | β23,135.3% | 52.2% | β140,497.1% | β45,991.7% | β449,214.3% | β407,940.0% | β12,000.0% |
| EBITDA margin | β1,837.2% | β1,118.0% | β40,379.4% | β23,127.1% | 52.2% | β140,485.7% | β45,977.1% | β449,085.7% | β407,520.0% | β11,985.8% |
| Net margin | β1,843.2% | β1,116.9% | β40,327.0% | β22,564.7% | 92.7% | β122,631.4% | β75,541.7% | β398,157.1% | β363,500.0% | β11,250.0% |
| FCF margin | β1,415.2% | β966.0% | β35,393.7% | β17,757.6% | 93.0% | β147,808.6% | β35,193.8% | β354,828.6% | β306,980.0% | β9,667.3% |
| Returns | ||||||||||
| Return on capital employed | β208.9% | β643.2% | β257.5% | β346.7% | 70.4% | β26.5% | β14.5% | β53.2% | β48.1% | β66.9% |
| Return on equity | β256.3% | β272.1% | β444.1% | β247.2% | 243.8% | β20.9% | β21.5% | β26.8% | β38.0% | β58.7% |
| Return on assets | β151.4% | β132.7% | β268.5% | β199.3% | 231.5% | β20.4% | β21.4% | β26.1% | β33.0% | β45.2% |
| Return on tangible equity | β256.3% | β1,112.6% | β256.9% | β340.8% | 124.9% | β23.1% | β23.8% | β49.8% | β45.9% | β81.1% |
| Growth | ||||||||||
| Revenue growth | β | β0.2% | β95.9% | 34.9% | 355,942.4% | β100.0% | 37.1% | β85.4% | β28.6% | 3,140.0% |
| Net income growth | β | β | β | β | β | β115.3% | β | β | β | β |
| EPS growth | β | β | β | β | β | β115.3% | β | β | β | β |
| FCF growth | β | β | β | β | β | β118.4% | β | β | β | β |
| Share count change | β | 4.2% | 7.9% | 8.9% | 4.5% | β0.6% | β100.0% | 0.0% | 0.0% | 0.0% |
| Financial health | ||||||||||
| Current ratio | 3.2x | 1.2x | 5.4x | 3.2x | 21.7x | 166.0x | 208.3x | 42.9x | 5.3x | 10.7x |
| Quick ratio | 3.2x | 1.2x | 5.4x | 3.2x | 21.7x | 166.0x | 208.3x | 42.9x | 5.3x | 10.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.8% | 0.0% | 0.0% | 16.5% | 0.0% | 31.4% | 0.0% | 928.6% | 440.0% | 10.5% |
| Stock comp / revenue | 348.3% | 257.7% | 6,436.5% | 4,365.9% | 1.3% | 11,954.3% | 6,937.5% | 39,685.7% | 38,040.0% | 1,216.0% |
| Payouts / FCF | β | β | β | β | 25.2% | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 2.0 | 3.0 | 2.0 | 6.0 | 2.0 | 4.0 | 2.0 | 3.0 | 4.0 |
| Altman Z'' | β32.1 | β95.0 | β59.4 | β105.6 | 33.1 | 185.8 | 222.4 | 5.5 | β7.9 | β20.7 |
| Accruals ratio | β35.2% | β17.9% | β32.8% | β42.6% | β0.8% | 4.2% | β11.4% | β2.9% | β5.2% | β6.4% |
Source: SEC EDGAR XBRL filings (CIK 0001082324). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.